Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ole Schmitz

Showing results (11-20 of 84) with videos related to

Pageof 9
Sort By:
Ugeskrift for Laeger|June 8, 2002
[Coffee and diabetes--something to be really concerned about?]Per Løgstrup Poulsen, Niels Møller, Ole Schmitz, et al.
Diabetes Care|May 27, 2004
Improved glycemic control with no weight increase in patients with type 2 diabetes after once-daily treatment with the long-acting glucagon-like peptide 1 analog liraglutide (NN2211): a 12-week, double-blind, randomized, controlled trialSten Madsbad, Ole Schmitz, Jonas Ranstam, et al.
Expert Review of Gastroenterology & Hepatology|December 17, 2008
Role of nonalcoholic fatty liver disease in the development of insulin resistance and diabetesHenning Grønbaek, Karen Louise Thomsen, Jørgen Rungby, et al.
Diabetes Care|January 30, 2002
Optimizing insulin secretagogue therapy in patients with type 2 diabetes: a randomized double-blind study with repaglinideOle Schmitz, Sten Lund, Per Heden Andersen, et al.
American Journal of Physiology. Endocrinology and Metabolism|November 4, 2004
Characterization of beta-cell function impairment in first-degree relatives of type 2 diabetic subjects: modeling analysis of 24-h triple-meal testsAndrea Mari, Amalia Gastaldelli, Andrea Natali, et al.
American Journal of Physiology. Endocrinology and Metabolism|October 22, 2002
Meal and oral glucose tests for assessment of beta -cell function: modeling analysis in normal subjectsAndrea Mari, Ole Schmitz, Amalia Gastaldelli, et al.
Obesity Research|August 16, 2002
Preferential stimulation of abdominal subcutaneous lipolysis after prednisolone exposure in humansClaus Højbjerg Gravholt, Rolf Dall, Jens Sandahl Christiansen, et al.
Diabetes Care|May 1, 2007
Effects of the long-acting human glucagon-like peptide-1 analog liraglutide on beta-cell function in normal living conditionsAndrea Mari, Kristine Degn, Birgitte Brock, et al.
International Journal of Cardiology|January 30, 2009
Short-term changes in circulating insulin and free fatty acids affect Nt-pro-BNP levels in heart failure patientsMads Halbirk, Helene Nørrelund, Niels Møller, et al.
The Journal of Clinical Endocrinology and Metabolism|August 14, 2003
Influence of rosiglitazone treatment on beta-cell function in type 2 diabetes: evidence of an increased ability of glucose to entrain high-frequency insulin pulsatilityClaus B Juhl, Malene Hollingdal, Niels Pørksen, et al.
Pageof 9

Showing results (11-20 of 84) with videos related to

Sort By:
Pageof 9
Ugeskrift for Laeger|June 8, 2002
[Coffee and diabetes--something to be really concerned about?]Per Løgstrup Poulsen, Niels Møller, Ole Schmitz, et al.
Diabetes Care|May 27, 2004
Improved glycemic control with no weight increase in patients with type 2 diabetes after once-daily treatment with the long-acting glucagon-like peptide 1 analog liraglutide (NN2211): a 12-week, double-blind, randomized, controlled trialSten Madsbad, Ole Schmitz, Jonas Ranstam, et al.
Expert Review of Gastroenterology & Hepatology|December 17, 2008
Role of nonalcoholic fatty liver disease in the development of insulin resistance and diabetesHenning Grønbaek, Karen Louise Thomsen, Jørgen Rungby, et al.
Diabetes Care|January 30, 2002
Optimizing insulin secretagogue therapy in patients with type 2 diabetes: a randomized double-blind study with repaglinideOle Schmitz, Sten Lund, Per Heden Andersen, et al.
American Journal of Physiology. Endocrinology and Metabolism|November 4, 2004
Characterization of beta-cell function impairment in first-degree relatives of type 2 diabetic subjects: modeling analysis of 24-h triple-meal testsAndrea Mari, Amalia Gastaldelli, Andrea Natali, et al.
American Journal of Physiology. Endocrinology and Metabolism|October 22, 2002
Meal and oral glucose tests for assessment of beta -cell function: modeling analysis in normal subjectsAndrea Mari, Ole Schmitz, Amalia Gastaldelli, et al.
Obesity Research|August 16, 2002
Preferential stimulation of abdominal subcutaneous lipolysis after prednisolone exposure in humansClaus Højbjerg Gravholt, Rolf Dall, Jens Sandahl Christiansen, et al.
Diabetes Care|May 1, 2007
Effects of the long-acting human glucagon-like peptide-1 analog liraglutide on beta-cell function in normal living conditionsAndrea Mari, Kristine Degn, Birgitte Brock, et al.
International Journal of Cardiology|January 30, 2009
Short-term changes in circulating insulin and free fatty acids affect Nt-pro-BNP levels in heart failure patientsMads Halbirk, Helene Nørrelund, Niels Møller, et al.
The Journal of Clinical Endocrinology and Metabolism|August 14, 2003
Influence of rosiglitazone treatment on beta-cell function in type 2 diabetes: evidence of an increased ability of glucose to entrain high-frequency insulin pulsatilityClaus B Juhl, Malene Hollingdal, Niels Pørksen, et al.
Pageof 9